Description: Tecan Group Ltd. provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company develops, produces, markets, and supports automation workflow solutions, including laboratory instruments, software packages, application knowhow, services, consumables, and spare parts; and develops and manufactures original equipment manufacturer instruments and components. Its products include liquid handling and automation products, microplate readers and washers, software, consumables, immunoassays and antibodies, and microarray products. The company operates in Switzerland, Euro-zone countries, Other European countries, North America, Asia, and other countries. Tecan Group Ltd. was founded in 1980 and is headquartered in Männedorf, Switzerland.
Home Page: www.tecan.com
Seestrasse 103
Männedorf,
8708
Switzerland
Phone:
41 44 922 88 88
Officers
Name | Title |
---|---|
Dr. Achim von Leoprechting Ph.D. | CEO & Member of Management Board |
Ms. Tania Micki B.A., M.B.A. | CFO & Member of Management Board |
Mr. Gunter Weisshaar | Sr. VP, Head of Quality Assurance & Regulatory Affairs and Member of Management Board |
Mr. Andreas Wilhelm | Exec. VP, Gen. Counsel, Sec. of the Board of Directors & Member of Management Board |
Mr. Martin Brandle | Sr. VP of Corp. Communications & Investor Relations and Member of Management Board |
Dr. Klaus Lun M.B.A., M.Sc., Ph.D. | Exec. VP, Member of Management Board & Head of the Life Sciences Bus. Division |
Dr. Ulrich Kanter | Exec. VP, Global Head of Operations & IT and Member of Management Board |
Mr. Erik Norström B.Sc., M.Sc. | Head of Corp. Devel., Exec. VP & Member of Management Board |
Dr. Wael Yared | CTO, Exec. VP, Head R&D & Member of the Management Board |
Mr. Ralf Griebel | Exec. VP, Head of the Partnering Bus. Division & Member of the Management Board |
Exchange: PINK
Country: US
Currency: US Dollar ($)
Forward PE: | 28.169 |
---|---|
Trailing PE: | 47.2057 |
Price-to-Book MRQ: | 3.6305 |
Price-to-Sales TTM: | 5.3609 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 3000 |